Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2007-07-31
2007-07-31
Minnifield, Nita M. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S269100, C424S184100
Reexamination Certificate
active
10779249
ABSTRACT:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.
REFERENCES:
patent: 4396600 (1983-08-01), Messineo et al.
patent: 6765838 (2004-07-01), Matsumoto et al.
patent: 2003/0039666 (2003-02-01), Weinstock et al.
patent: 2004/0202671 (2004-10-01), Weinstock et al.
patent: 2004/0253709 (2004-12-01), Schramm et al.
patent: 2005/0118655 (2005-06-01), Weinstock et al.
patent: 2006/0024333 (2006-02-01), O'Connor
patent: 0 524 834 (1993-01-01), None
patent: WO 93/23063 (1993-11-01), None
patent: WO 95/24425 (1995-09-01), None
patent: WO 96/29082 (1996-09-01), None
patent: WO 99/33479 (1999-07-01), None
patent: WO 00/25810 (2000-05-01), None
patent: WO 2006/014907 (2006-02-01), None
Bellon et al, J. Clin. Lab. Immunol., 1982, 8:133-136.
Dangolla et al, Preventive Vet. Medicine, 1996, 27:197-209.
Ely et al, Lab. Animal Science, 1994, 44/3:211-216.
Swindle, J. Investigative Surgery, 1996, 9:267-271.
Petkevicius et al, Helminthologia, 1996, 33/4:173-180.
Eriksen et al, Vet. Parasitology, 1992, 41:137-149.
Wynn et al, J. Immunology, 1998, 160:4473-4480.
Oswald et al, J. Immunology, 1994, 153:1707-1713.
Pearce et al, J. Expt. Med., 1991, 173:159-166.
Pearce et al, PNAS, USA, 1988, 85:5678-5682.
Metwali et al, J. Immunology, 1996, 157:4546-4553.
Kullberg et al, J. Immunology, 1992, 148/10:3264-3270.
Bancroft et al, Eur. J. Immunol., 1994, 24:3113-3118.
Bowman et al, Folia Parasitology, 1991, 38:245-253.
Elliott, METHODS: A Companion to Methods in Enzymology, 1996, 9:255-267.
Coker et al, Proceedings Soc. for Exp. Biol. and Med., 1956, 92:780-782.
Elise et al, Parasitology, 1990, 100:479-489.
Brown et al, Center for Tropical and Subtropical Aquaculture Publication No. 116: I-IV, pp. 1, 3-28, 1995.
Thaumaturgo et al, Mem. Inst. Oswaldo Cruz, Rio de Janeiro, 2001, 96/Suppl.: 79-83.
Sewell et al, International Immunology, 2003, 15/1:59-69.
Elliott et al, Gastroenterology, 2002, 122/4 Suppl 1:A389 abstract only.
Elliott et al, Am. J. Physiol. Gastroenterol. Liver Physiol., 2003, 284:G385-G391.
Imai et al, Current Topics in Medicinal Chemistry, 2004, 4:539-552.
Harnett et al, Current Topics in Medicinal Chemistry, 2004, 4:553-559.
McInnes et al, J. Immunology, 2003, 171:2127-2133.
Nagayama et al, J. Immunology, 2004, 173:2167-2173.
Summers et al, Applied J. Gastroenterology, 2003, 98/9:2034-2035.
Elliott et al, Current Opinion Gastroenterology, 2004, 21:51-56.
Elliott, Gastroenterology Clinics of North America, 1996, 25/3:599-625.
Summers et al, Gut, 2005, 54:87-90.
Elliott et al, Digestive and Liver Disease, 2000, 32/Suppl. 1:A26 abstract only.
Summers et al, Digestive and Liver Disease, 2000, 32/Suppl. 1:A26 abstract only.
Summers et al, Gastroenterology, 2005, 128:825-832.
Summers et al, Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2/2:62-63.
Metwali et al, Gastroenterology, Apr. 2006, 130/No. 4, Suppl. 2, p. A41 meeting abstract.
Barriga, O.O., (1978), “Depression of cell-mediated immunity following inoculation ofTrichinella spiralisextract in the mouse”,Immunology, 34:167-173.
Dreyer, G. et al., (1996), “Patterns of Detection ofStrongyloides stercoralisin Stool Specimens: Implications for Diagnosis and Clinical Trials”,Journal of Clinical Microbiology, 34(10): 2569-2571.
PCT International Search Report of Application No. PCT/US98/26458, 1998.
Supplementary Partial European Search Report of Application No. EP 98 96 3124, 1998.
Elliott David E.
Weinstock Joel V.
Edwards Angell Palmer & Dodge
Minnifield Nita M.
University of Iowa Research Foundation
LandOfFree
Use of parasitic biological agents for prevention and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of parasitic biological agents for prevention and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of parasitic biological agents for prevention and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3722596